The Conference will truly reflect the current trends, new strategies, recent advances, new approaches and future trends in Toxicology, and Pharmacology. The Summit will cover among others: Mechanisms and modes of action of various toxins, and Pharmaceuticals, Clinical and Forensic toxicology, Omics technologies, Emerging in vitro models, strategies in Toxicology and Pharmacology, Forensic Toxicol
Cannabis testing involves quantification of major chemical compound and active ingredient in the given specimen of cannabis. Cannabinoids and terpene are major active ingredient that has medicinal potency.
An electronic medical record (EMR) is a structured collection of patients’ health information in a digital format. These records can be shared across different healthcare settings such as hospitals, clinics, and ambulatory surgical centers.
Assessing device development and regulation for advanced innovation.
SMi’s 6th Annual Conference
Pre-Filled Syringes West Coast
June 13 - 14, 2022 | San Diego, CA, USA
http://www.prefilled-syringes-westcoast.com/1888pressrelease
A computerized physician order entry (CPOE) system, also called Computerized Provider Order Entry, is a healthcare information system that electronically captures and stores physician's instructions and helps improve efficiency of patient-care management.
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions.
SMi Group reports: Key pressing questions on rapid microbial methods, contamination control, sterility assurance and environmental monitoring will be addressed at the Microbiology East Coast Conference in Boston this April 2022.
SMi Reports: Chemaxon release an interview prior to joining the SMi’s 3rd Annual AI in Drug Discovery Conference on 14-15 March 2022 in London as a key sponsor.
SMi Group reports: Invitation letter released from Jim Polarine at STERIS who is chairing the 5th Annual Pharmaceutical Microbiology East Coast Conference.
SMi Group Reports: The leading Pain Therapeutics Conference will take place for its 22nd consecutive year on 4th and 5th May 2022 in London, UK to explore novel compounds and treatments for pain: opioids and the alternatives.
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3nd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK.
SMi Group reports: new speakers from Abbvie, GSK, Scripps Research and Engitix Therapeutics join the 5th Annual 3D Cell Culture Conference in February 2022.
Scitara Corp, a proven innovator in laboratory digital transformation, today announces the closing of its Series B round with an additional investment of $15m.
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety.
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022.
SMi Group reports: Scientists to join 3rd Annual AI in Drug Discovery Conference to learn about the breakthroughs in clinical trials in ai drug discovery.
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.
SMi Group outlines seven key takeaways attendees can gain from joining the Pharmaceutical Microbiology Conference on 17 and 18 January 2021 in London, UK.
SMi Group reports: the 3rd Annual AI in Drug Discovery is set to return to London in March 2022 with a key focus on the opportunities of machine learning and AI in drug development.
Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply.
Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML, and radioactive iodine resistant advanced thyroid carcinoma.
SMi Reports: Leading pharmaceutical microbiologists and industry experts to meet at SMi’s 10th Anniversary Pharmaceutical Microbiology UK Conference taking place in London on 17-18 January 2022.